192 results
DEFA14A
HBIO
Harvard Bioscience Inc.
3 Apr 24
Additional proxy soliciting materials
4:46pm
(as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Under Rule 14a-12
Harvard … Bioscience, Inc.
Payment of Filing Fee (Check all boxes that apply):
No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
8-K
EX-10.1
wg3za5 w4g5l4t5g9
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
SD
EX-1.01
m4kp39vqj3zyjcmv0i
30 May 23
Conflict minerals disclosure
4:17pm
8-K
EX-99.1
wsyewv8k0p9
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
SD
EX-1.01
kowkdoamu
20 May 22
Conflict minerals disclosure
4:15pm
DEFA14A
x56i8k0y
7 Apr 22
Additional proxy soliciting materials
4:40pm
8-K
EX-10.1
ah1rvzd5xx6u8gdom78
27 Jan 22
Entry into a Material Definitive Agreement
9:34pm